Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator

Table 4 Multivariable analysis of CMR parameters for the prediction of appropriate implantable cardioverter defibrillator therapy or death

Variables	Adjusted HR	95% CI	p	Harrell's C	Somers' D
LVMI excluding TPM, per 10 g/m²	1.126	1.032–1.228	0.008	0.600	0.200
LVMI including TPM, per 10 g/m²	1.099	1.027–1.175	0.006	0.597	0.194
LVEDVI, excluding TPM, per 10 ml/m²	1.034	0.993–1.075	0.10	0.558	0.115
LVEDVI, including TPM, per 10 ml/m²	1.033	0.989–1.080	0.17	0.559	0.118
LVESVI excluding TPM, per 10 ml/m²	1.044	1.002–1.087	0.038	0.565	0.131
LVESVI, including TPM, per 10 ml/m²	1.044	0.998–1.093	0.061	0.569	0.139
LVEF excluding TPM, per 10%	0.780	0.639–0.951	0.014	0.590	0.181
LVEF including TPM, per 10%	0.814	0.688–0.962	0.016	0.588	0.175
RWT	0.901	0.069–11.710	0.936	0.561	0.122

All models adjusted for age, primary prevention, ischemic heart disease, and presence of late gadolinium enhancement
HR hazard ratio, CI confidence interval, LVMI left ventricular mass index, LVEDVI left ventricular end-diastolic volume index, LVESVI left ventricular end-systolic volume index, LVEF left ventricular ejection fraction, LVMI left ventricular mass index, RWT relative wall thickness, TPM trabeculae and papillary muscles

ISSN: 1532-429X